FIELD: medicine.
SUBSTANCE: invention relates to medicine, oncology, and can be used for chemoradiation therapy of low-located tumours of rectum and anal canal. For this purpose standard teleirradiation is performed. Additionally performed is conformal intraluminal brachytherapy of high power dose 5-10 Curie 4-6 irradiation sessions with reference dose 3.5 Gy at depth of 10 mm from irradiation source. In addition, on daily basis derivative of capecitabine fluoropyrimidines in amount 600 mg/m2 is introduced per os.
EFFECT: method allows to increase treatment efficiency, increase local response of tumour and reduce risk of metastases development due to exposing tumour to higher tumoricidal doses of irradiation and adding brachytherapy, intake of capecitabine enhancing local regress and reducing risk of tumour metastasis.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CHEMORADIATION OF RECTUM AND ANAL CANAL TUMORS | 2016 |
|
RU2629599C1 |
METHOD OF TREATING LOCALLY ADVANCED UNRESECTABLE OESOPHAGEAL CANCER | 2011 |
|
RU2468836C1 |
METHOD OF TREATMENT OF LOCALLY ADVANCED SQUAMOUS CELL CANCER OF ANAL CANAL | 2023 |
|
RU2809447C2 |
METHOD OF COMBINATION TREATMENT OF LOCALLY ADVANCED RECTAL CANCER | 2015 |
|
RU2599043C1 |
METHOD FOR TREATING LOW-LYING TUMORS OF RECTUM AND ANAL CANAL | 2017 |
|
RU2666694C1 |
METHOD OF COMBINATION TREATMENT OF LOCALLY ADVANCED RECTAL CANCER | 2010 |
|
RU2447914C1 |
METHOD OF NEOADJUVANT THERMOCHEMORADIATION TREATMENT OF RECTAL CANCER | 2018 |
|
RU2704205C2 |
METHOD OF TREATING SQUAMOUS CELL CANCER OF ANAL CANAL | 2011 |
|
RU2459644C1 |
METHOD FOR COMBINED TREATMENT OF PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER USING NEOADJUVANT RADIATION THERAPY AND CONSOLIDATING CHEMOTHERAPY | 2021 |
|
RU2770989C2 |
METHOD FOR TREATMENT OF ANAL CANCER WITH SKIN TRANSITION | 2016 |
|
RU2638616C1 |
Authors
Dates
2010-09-27—Published
2009-06-22—Filed